Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Exercise on Ovarian Cancer Prognosis

NCT02107066 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02107066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Exercise on Ovarian Cancer Prognosis
Lead sponsor
Yale University
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2009
Completion date
June 30, 2013
Enrollment
144 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer